Afghanistan Pharmacy Technician Exit Exam study materials
Afghanistan Pharmacy Technician Exit Exam study resources

Afghanistan Pharmacy Technician Exit Exam cheat sheet

Afghanistan Pharmacy Technician Exit Exam · Keep the key ideas within reach.

Quick reference

Pharmacy Law, Ethics, and Professional Practice

  • A prescription is valid only if it contains prescriber name and signature, patient name, drug name, strength, dosage form, quantity, directions, and date.

  • Schedule II-type controlled substances (e.g., morphine, pethidine) require a written prescription, no refills, and must be dispensed within the legal time window set by national regulation.

  • Refills are permitted only when the prescriber authorizes them in writing; the total quantity dispensed may not exceed the authorized amount.

  • A pharmacist may substitute a generic product only when local law permits and the prescriber has not written 'no substitution' (dispense as written).

  • Patient records must be kept confidential; disclosure requires patient consent or a legal order, and records are retained per national retention rules.

  • Prescriptions must be retained on file for the legally required period and be available for inspection by authorized inspectors.

  • A technician must never independently counsel, verify, or release a prescription; those acts remain the pharmacist's legal responsibility.

  • Reporting of suspected counterfeit, substandard, or falsified medicines to the national regulatory authority is a professional obligation.

  • Conflict of interest: gifts or incentives from suppliers that could influence purchasing decisions must be declined or disclosed.

Quick reference

Pharmacology and Drug Classification

  • Beta-lactams (penicillins, cephalosporins) inhibit bacterial cell wall synthesis; aminoglycosides bind the 30S ribosome and are nephrotoxic and ototoxic.

  • NSAIDs inhibit cyclooxygenase, reducing prostaglandin synthesis; they cause gastric irritation and can worsen renal function and asthma.

  • Opioids act on mu receptors producing analgesia, respiratory depression, constipation, and dependence; naloxone reverses opioid overdose.

  • ACE inhibitors lower blood pressure by blocking angiotensin II formation; a dry cough and hyperkalemia are characteristic adverse effects.

  • Statins inhibit HMG-CoA reductase; myopathy and elevated liver enzymes are key monitoring concerns.

  • Anticoagulants: warfarin inhibits vitamin K-dependent clotting factors and is monitored by INR; heparin is monitored by aPTT.

  • Corticosteroids suppress inflammation and immunity; long-term use causes hyperglycemia, osteoporosis, and adrenal suppression on abrupt withdrawal.

  • Antituberculosis therapy uses combination regimens (e.g., isoniazid, rifampicin, pyrazinamide, ethambutol) to prevent resistance; isoniazid causes peripheral neuropathy.

  • Antimalarials and antidiabetics (insulin, metformin) must be classified by mechanism, onset, and key adverse effects before dispensing.

Quick reference

Pharmaceutical Calculations and Measurement

  • Dose = (desired dose / stock strength) x stock volume, keeping units consistent before calculating.

  • Percentage solutions: % w/v = grams per 100 mL; % w/w = grams per 100 g; % v/v = mL per 100 mL.

  • Dilution formula: C1 x V1 = C2 x V2, used for reconstituting or diluting stock solutions.

  • Alligation method: ratio of parts = (higher % - desired %) : (desired % - lower %).

  • Body surface area (BSA) by Mosteller = square root of (height in cm x weight in kg / 3600); BSA-based dosing uses mg/m2.

  • Pediatric dose by Clark's rule = (weight in kg / 70) x adult dose; Young's rule uses age in years.

  • IV drip rate (drops/min) = (volume in mL x drop factor in drops/mL) / time in minutes.

  • Unit conversions: 1 g = 1000 mg; 1 mg = 1000 mcg; 1 L = 1000 mL; 1 kg = 2.2 lb.

  • Always round final measured quantities to the precision the dosage form and measuring device can deliver.

Quick reference

Dispensing, Prescription Processing, and Labeling

  • Processing order: receive and validate prescription, check patient record and allergies, interpret, prepare, label, pharmacist check, then release.

  • The label must show patient name, drug name and strength, directions, quantity, date, pharmacy identity, and any cautionary or storage statements.

  • Auxiliary labels must be applied for specific risks: 'take with food', 'avoid alcohol', 'shake well', 'for external use only', 'keep out of reach of children'.

  • Prescription interpretation errors (illegible handwriting, missing strength, ambiguous abbreviations) require clarification with the prescriber, not guessing.

  • Abbreviations that must be avoided: 'U' (write 'units'), 'QD'/'OD' (write 'once daily'), and trailing zeros (write 5 mg, not 5.0 mg).

  • Dispensing containers must be appropriate to the product: light-resistant for photosensitive drugs, tight-closing for volatile or hygroscopic products, child-resistant where required.

  • The final check compares the prescription against the prepared product: drug, strength, dosage form, quantity, label, and expiry date.

  • Dispensing records must allow traceability of the batch number dispensed to the patient.

Quick reference

Pharmaceutical Dosage Forms and Compounding

  • Tablets may be compressed, coated, chewable, sublingual, or effervescent; enteric coatings protect against gastric acid and must not be crushed.

  • Capsules are gelatin shells containing powder, granules, or liquid; they must be stored away from moisture and heat to avoid shell softening.

  • Suspensions are biphasic and must be shaken before use; emulsions are oil-in-water or water-in-oil and can crack on freezing or incompatible additives.

  • Suppositories are solid at room temperature and melt or dissolve in body cavities; bases include cocoa butter and polyethylene glycol.

  • Sterile products (injections, eye drops) require aseptic technique, preservative considerations, and, for multi-dose vials, a defined in-use expiry.

  • Compounding follows a master formula: ingredients, quantities, method, equipment, and quality checks are documented for each preparation.

  • Incompatibilities to check when compounding: pH-dependent precipitation, oxidation, complexation, and physical separation of emulsion phases.

  • Geometric dilution is used to mix a small quantity of potent powder uniformly with a larger diluent.

  • Compounded preparations require a beyond-use date based on the product's stability, preservative content, and storage conditions.

Quick reference

Drug Interactions, Adverse Effects, and Patient Counseling

  • Pharmacodynamic interactions occur at the same receptor or physiological system (e.g., two sedatives causing additive CNS depression).

  • Pharmacokinetic interactions alter absorption, distribution, metabolism, or excretion (e.g., enzyme inducers like rifampicin lower warfarin effect).

  • Warfarin interactions: NSAIDs, aspirin, and many antibiotics increase bleeding risk; INR monitoring is required.

  • MAO inhibitors with tyramine-rich foods or sympathomimetics can precipitate hypertensive crisis.

  • Adverse effects to counsel on: drowsiness with antihistamines, photosensitivity with tetracyclines, and GI upset with oral iron.

  • Counseling must cover dose, frequency, route, timing relative to food, missed-dose handling, and duration of therapy.

  • Patients should be told to report serious adverse effects and to avoid doubling doses to make up for a missed dose.

  • Special populations (pregnancy, breastfeeding, children, elderly, renal or hepatic impairment) require dose adjustment and extra counseling.

  • Storage counseling: keep medicines out of reach of children, away from heat and moisture, and never share prescription medicines.

Quick reference

Inventory Management, Storage, and Drug Quality

  • First Expiry First Out (FEFO) rotation ensures the earliest-expiring stock is dispensed first; First In First Out (FIFO) is used when expiry dates are uniform.

  • Stock records must track receipt, issue, balance, batch number, and expiry date for every product.

  • Cold-chain products (e.g., insulin, some vaccines) require 2-8 degrees C storage with continuous temperature monitoring and a documented excursion procedure.

  • Expired, damaged, or recalled stock must be segregated in a labeled quarantine area and disposed of according to national regulations.

  • Narcotics and controlled substances require locked storage, restricted access, and a running balance record with periodic reconciliation.

  • Physical inventory counts are reconciled against records; discrepancies above a defined threshold trigger investigation.

  • Signs of quality failure: discoloration, change in odor or texture, caking, leakage, cracked tablets, and particulate matter in solutions.

  • Storage conditions to control: temperature, humidity, light exposure, and ventilation; direct sunlight degrades many photosensitive drugs.

Quick reference

Infection Control, Safety, and Public Health

  • Hand hygiene is the single most effective measure against cross-infection; wash with soap and water or use alcohol-based rub before and after contact.

  • Standard precautions apply to all patients: gloves for body fluid contact, eye protection when splashing is possible, and safe sharps handling.

  • Sharps must never be recapped by hand; place them immediately in a puncture-resistant, labeled sharps container.

  • Spills of blood or body fluids are cleaned with absorbent material and disinfected with an appropriate agent such as sodium hypochlorite solution.

  • Vaccination reduces disease transmission; cold-chain integrity and correct administration technique are essential for vaccine effectiveness.

  • Antimicrobial resistance is slowed by completing prescribed courses, avoiding unnecessary antibiotics, and not sharing antibiotics.

  • Public health reporting: certain infectious diseases and serious adverse drug reactions must be reported to health authorities.

  • Hazardous drug handling (e.g., cytotoxic medicines) requires protective equipment and dedicated preparation areas.